news

Jiete Bio: Yuan Jianhua, one of the actual controllers, increased his holdings by approximately 390,000 shares, and the increase plan has been implemented

2024-08-17

한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina

Meijing AI News,Jiete Biotech (SH 688026, closing price: 11.63 yuan) announced on the evening of August 16 that the implementation results of the share purchase plan: from February 26, 2024 to August 16, 2024, the company's controlling shareholder, one of the actual controllers and chairman, Mr. Yuan Jianhua, has accumulated approximately 390,000 shares of the company through the Shanghai Stock Exchange trading system in a centralized bidding transaction, accounting for 0.28% of the company's total share capital, and the total amount of the increase is RMB 5.002 million. This share purchase plan has been implemented.

From January to December 2023, the operating income structure of Jiete Bio was as follows: consumables revenue accounted for 97.04%.

As of press time, the market value of Jiete Bio was 1.6 billion yuan.

Daoda No. (daoda1997) "Stock Trend" reminder:

1. In the past 30 days, the northbound funds' holdings of Jiete Biotechnology decreased by 404,200 shares, and the proportion of outstanding shares decreased by 0.28%;

2. No organization has conducted research on Jiete Biotech in the past 30 days;

3. The last time Jie Te Bio released an announcement of share purchase was on February 27, 2024. The stock price fell by 9.03% on the second trading day. Jie Te Bio has issued three announcements of share purchase in the past year.

Every headline (nbdtoutiao)——

(Reporter Wang Xiaobo)

Disclaimer: The content and data in this article are for reference only and do not constitute investment advice. Please verify before use. You will be responsible for your own risks if you act accordingly.

Daily Economic News